ALCAT1 promotes diabetic cardiomyopathy by linking myocardial tetralinoleoyl cardiolipin deficiency to lipotoxicity. [PDF]
Jia D, Shi Y.
europepmc +1 more source
The lipid-podocyte axis: emerging clues in membranous nephropathy pathogenesis. [PDF]
Ma S +6 more
europepmc +1 more source
Dysfunctional Lipid-Induced Secretion of Glucagon-Like Peptide-2(GLP-2), but Not of Incretins Glucagon-Like Peptide-1(GLP-1)/Glucose-Dependent Insulinotropic Polypeptide(GIP), Promotes Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Onset and Progression Through Gut Barrier Disruption and Endotoxemia. [PDF]
Musso G +9 more
europepmc +1 more source
Palmitate impairs autophagic degradation via oxidative stress/perilysosomal Ca2+ overload/mTORC1 activation pathway in pancreatic β cells. [PDF]
Nguyen HT +13 more
europepmc +1 more source
Ginsenosides for the Management of Metabolic Dysfunction-Associated Fatty Liver Disease: A Research Update. [PDF]
Zhang K +5 more
europepmc +1 more source
Fatty Acids and Their Roles in Cardiac Physiology and Pathology: Mechanistic and Interventional Studies. [PDF]
Mallick R +3 more
europepmc +1 more source
FATP2 at the crossroads of fatty acid transport, lipotoxicity, and complex disease. [PDF]
Black PN, DiRusso CC.
europepmc +1 more source
Imbalance of mitochondria and abnormalities in lipid metabolism in Diabetic Tubulopathy. [PDF]
Sun C, Li Y, Tao Y, Wu Q, Liu B, Zhou Y.
europepmc +1 more source
Related searches:
Cardiomyopathy is associated with both rare genetic metabolic abnormalities and highly prevalent diseases characterized by elevated serum triglycerides and nonesterified fatty acids, such as obesity and type 2 diabetes. In these disorders, an imbalance between fatty acid uptake and utilization leads to the inappropriate accumulation of free fatty acids
Nica M, Borradaile, Jean E, Schaffer
openaire +2 more sources

